US$ 21.11
dosing for ghk-cu peptide subcutaneous protocol ghk-cu administration subcutaneous GHK-Cu Dosage and Protocol: A Medical Provider's Guide to the 30 ghk cu 100mg peptide dosage
Description
This concentration is similar to that used in GHK-Cu preparations for aging skin

Thymosin Alpha-1's approval record in more than 30 countries is frequently cited as evidence that the FDA's risk characterization is inconsistent with global clinical experience

May be repeated once or twice weekly, as indicated by condition and response
10.1073/pnas.0906773106 71

Hematoma thickness decreased by at least 50% at 180 days post-procedure in 29 patients (72.5%) with at least one follow-up CT scan, except for one patient whose hematoma remained stable
